To determine whether an anti-TCP1 antibody could serve as a potential biomarker for SLE, this study aims to elucidate the potential role of anti-TCP1 antibody as a biomarker in SLE, contributing to a deeper understanding of the disease mechanisms and paving the way for future research in autoimmune diagnostics and therapeutics. The gene discussed is TCP1; the disease is systemic lupus erythematosus.